Studies on the toxicity of analogues of dapsone in-vitro using rat, human and heterologously expressed metabolizing systems

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 9, 1996, Pages 945-950

  Coleman, Michael D ^a   Smith, Stephen N ^a   Kelly, Diane E ^b   Kelly, Steven L ^b   Seydel, Joachim K ^c  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DAPSONE; DAPSONE DERIVATIVE; DRUG ANALOG; DRUG METABOLIZING ENZYME; METHEMOGLOBIN; SULFONE DERIVATIVE; TRIMETHOPRIM DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; HUMAN TISSUE; LIVER; LIVER MICROSOME; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; RAT;

EID: 0029958064     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb06008.x     Document Type: Article

References (39)

1. Boyum, A. (1976) Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. 5:(Suppl. 5) 5-15
2. Ceppi, E., Eckhardt, W., Grob, C. A. (1973) 4-Substituted quinuclidium perchlorates in the determination of polar substituent effects. Tetrahedron Lett. 37: 3627-3630
3. Coleman, M. D. (1993) Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br. J. Dermatol. 129: 507-513
4. Coleman, M. D., Jacobus, D. P. (1993) Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in-vitro. II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma. Biochem. Pharmacol. 46: 1363-1368
5. Coleman, M. D., Breckenridge, A. M., Park, B. K. (1989) Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. Br. J. Clin. Pharmacol. 28: 389-395
6. Coleman, M. D., Scott, A. K., Breckenridge, A. M., Park, B. K. (1990a) The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man. Br. J. Clin. Pharmacol. 30: 761-767
7. Coleman, M. D., Tingle, M. D., Winn, M. J., Park, B. K. (1990b) Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat J. Pharm. Pharmacol. 42 698-703
8. Coleman, M. D., Tingle, M. D., Hussain, F., Storr, R. C., Park, B. K. (1991) An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro. J. Pharm. Pharmacol. 43: 779-784
9. Elashoff, J. D. (1981) Down with multiple t tests. Gastroenterology 80: 615-620
10. Fleming, C. M., Persad, R., Kaisary, A., Smith, P., Adedoyin, A., Porter, J., Wilkinson, G. R., Branch, R. A. (1994) Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer. Pharmacogenetics 4: 199-207
11. Gillam, E. M. J., Baba, T., Kim, B. R., Ohmori, S., Guengerich, F. P. (1993) Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305 123-131
12. Guengerich, F. P., Brian, W. R., Sari, M. A., Ross, J. T. (1991) Expression of mammalian cytochrome P-450 enzymes using yeast vectors. Methods Enzymol. 206: 130-144
13. Israili, Z. H., Cucinell, S. A., Vaught, J., Davis, B., Zesser, J. M., Dayton, P. G. (1973) Studies of the metabolism of DDS in man and experimental animals. Formation of N-hydroxy metabolites. J. Pharmacol. Exp. Ther. 187: 138-151
14. Kansy, M., Seydel, J. K., Wiese, M., Haller, R. (1992) Synthesis of new 2,4, diaminobenzylpyrimidines active against various bacterial species. Eur. J. Med. Chem. 27: 237-244
15. Kenna, S., Bligh, H. F., Watson, P. F., Kelly, S. L. (1989) Genetic and physiological analysis of azole sensitivity in Saccharomysces cerevisiae. J. Med. Vet. Mycol. 27 397-406
16. Kiese, M., Reinwein, D., Waller, H. D. (1950) Kinetik der Hamiglobinbildung. IV Mitteilung. Die Hamiglobinbildung durch Phenylhydroxylamin und Nitrosobenzol in roten Zellen in vitro. Naunyn Schmiedebergs Arc. Exp. Path. Pharmacol. 210: 393-398
17. Koehler, M. G., Hopfinger, A. J. (1988) A comparison of QSARs proposed for the inhibition of dihydropteroate synthetase by substituted 4-aminodiphenylsulfones. J. Mol. Structure (Theochem) 179: 319-332
18. Koley, A. P., Buters, J. T. M., Robinson, R. C., Markowitz, A., Friedman, F. K. (1995) CO binding kinetics of human cytochrome P-450 3A4. J.Biol. Chem. 270: 5014-5018
19. Kramer, P. A., Glader, B. E., Li, T. K. (1972) Mechanism of methaemoglobin formation by diphenylsulphones. Biochem. Pharmacol. 21: 1265-1274
20. Lee, B. L., Medina, I., Benowitz, N. L., Jacob, P., Wofsy, C. B., Mills, J. (1989) Dapsone, trimethoprim and sulfamethoxazole plasma levels during treatment of pneumocystis pneumonia in patients with the acquired immune deficiency syndrome (AIDS). Ann. Intern. Med. 110: 606-611
21. Manfredi, G., De Panfilis, G., Zampetti, M., Allegra, F. (1979) Studies on dapsone-induced haemolytic anaemia: methaemoglobin production and glucose 6-phosphate activity in correlation with dapsone dosage. Br. J. Dermatol. 100: 427-432
22. Mitra, A. K., Kalhorn, T. F., Thummel, K. E., Unadkat, J. A., Slattery, J. T. (1993) Metabolism of arylamines by human liver microsomal cytochrome P-450(S). Proc. ISSX, Fifth North American Meeting, Tucson, AZ, USA, Oct 17-21, p. 148
23. Mitra, A. K., Thummel, K. E., Unadkat, J. A., Slattery, J .T. (1994) Metabolism of dapsone in human liver by cytochrome P-450 2E1. Proc. Sixth North American Meeting, Raleigh, NC, USA, Oct 23-27, p. 248
24. Nedelcheva, V., Gut, I. (1994) P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. Xenobiotica 24: 1151-1175
25. Omura, T., Sato, R. (1964) The carbon monoxide binding pigmant of liver microsomes. J. Biol. Chem. 239: 2370-2385
26. Pieper, H., Seydel, J. K., Kruger, G., Noll, K., Keck, J., Wiese, M. (1989) Preparation and biological activity of new substituted antimalarial diaminodiphenylsulfones. Arzn. Forsch. 39: 1073-1080
27. Pirmohamed, M., Coleman, M. D., Hussain, F., Breckenridge, A. M., Park, B. K. (1991) Direct and indirect toxicity of sulphasalazine and its principle metabolites towards human leucocytes and erythrocytes. Br. J. Clin. Pharmacacol. 32: 303-311
28. Purba, H. S., Maggs, J. L., Orme, M. L'E., Back, D. J., Park, B. K. (1987) The metabolism of 17αethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br. J. Clin. Pharmacol. 23: 447-453
29. Roth, B., Falco, E. A., Hitchings, G. H., Bushby, J. R. H. (1961) Trimethoprim, a novel antibacterial agent. J. Med. Chem. 5: 1103-1116
30. Soucek, P., Gut, I. (1992) Cytochromes P-450 in rats: structures, functions,properties and relevant human forms. Xenobiotica 22: 83-103
31. Spielberg, S. P. (1984) In-vitro assessment of pharmacogenetic susceptibility to toxic metabolites in humans. Fed. Proc. 43: 2308-2313
32. Schwartz, D. E., Vetter, W., Englert, G. (1970) Trimethoprim metabolites in the rat, dog and man: qualitative and quantitative studies. Arzeimittelforschung 20; 1867-1871
33. Tingle, M. D., Coleman, M. D., Park, B. K. (1990) Investigation into the role of metabolism in dapsone-induced methaemoglobinaemia using a two-compartment in-vitro test system. Br. J. Clin. Pharmacol. 30: 829-838
34. Tingle, M. D., Coleman, M. D., Park, B. K. (1991) Effects of pre-incubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes. Br. J. Clin. Pharmacol. 32: 120-124
35. Torres, R. A., Barr, M., Thorn, M., Gregory, G., Kiely, W., Chanin, E., Carlo, C., Nartin, M., Thornton, J. (1993) Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Am. J. Med. 95: 573-583
36. Vage, C., Svensson, C. K. (1994) Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P-450 2C6/2C11 and 3A1. Drug Metab. Dispos. 22: 572-577
37. Voeller, D., Kovacs, J., Andrawis, V., Chu E Masur, H., Allegra, C. (1994) Interaction of Pneumocystis carinii dihydropteroate synthetase with sulphonamides and diaminodiphenyl sulfone. J. Infect. Dis. 169: 456-459
38. Watkins, P. B. (1994) Non-invasive tests of CYP3A enzymes. Pharmacogenetics 4: 171-184
39. Wiese, M., Seydel, J. K., Pieper, H., Kruger, G., Noll, K. R., Keck, J. (1987) Multiple regression analysis of antimalarial activities of sulfones and sulfonamides in cell-free systems and principal component analysis to compare with antibacterial activities. Quant. Struct.-Act. Relat. 6: 164-172